A look at drugs in development for HIV treatment and prevention
Pregnancy and dolutegravir; AIDS Quilt finds a new home; survey on women living with HIV; and more
FDA approves Descovy for PrEP; Delstrigo and Pifeltro approved for switch treatment; Bictegravir, dolutegravir and Tybost for children; and more.
Based on new data, the World Health Organization (WHO) recommended dolutegravir as a preferred HIV drug for all populations living with HIV, including pregnant women and those wanting to conceive.
And other conference highlights including new long-acting drug GS-6207; PrEP on demand; HIV treatment = prevention.
Building blocks for a healthy life, with insights from a nurse educator
Biktarvy and antacids. Descovy FDA hearing. Updated guidelines for transgender individuals. Biktarvy and kids. PrEP4Love. Michael Johnson freed.
Monthly injectable HIV med on the way; HIV pharma sued over pricing practices; Australian PrEP advocate talks about his new HIV status; tenofovir class action lawsuits
New two-drug regimen gets FDA approval. Transgender filmmaker debuts new documentary. Project Inform closes. First kidney transplant from donor living with HIV.
Mixed emotions for a long-term survivor. Peer education in prison. Loving the HIV drug guides and charts.
The experience is your own, but you’re not alone in the room